The largest database of trusted experimental protocols

Protein inhibitor cocktail

Manufactured by Merck Group
Sourced in United States, Israel, Germany, Japan, China

The Protein Inhibitor Cocktail is a laboratory product designed to inhibit the activity of various proteins. It is a mixture of chemical compounds that can effectively suppress the function of specific proteins in a controlled experimental setting. The core function of this product is to provide a reliable tool for researchers to study the role and behavior of proteins in different biological systems.

Automatically generated - may contain errors

81 protocols using protein inhibitor cocktail

1

Western Blot Analysis of HCN Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was carried out for different HCN proteins (1-4) in the bladder tissue. Briefly, bladder tissue was homogenized using CelLytic™ MT Mammalian Tissue Lysis/Extraction Reagent (Sigma, USA) in the presence of phenylmethylsulfonyl fluoride (1 mM), sodium orthovanadate (2 mM) and protein inhibitor cocktail (Sigma, USA). Protein estimation was done by BCA Protein Assay Kit (Pierce, Rockford, Illinois). An equal amount (50 μg/well) of denatured proteins was loaded in 10% tricine-SDS gel and blotted on polyvinylidene fluoride (PVDF) membranes using wet transfer system. After blocking (2 h at 37°C), membranes were incubated overnight at 4°C with primary antibodies specific for HCN1, HCN4 and Actin-β (Santa Cruz Biotechnology), HCN2 and HCN3 (Abcam, USA), in blocking buffer (pH 7.5). The membranes were then re-incubated for 2 h at room temperature with secondary immunoglobulin G (IgG)-conjugated with horseradish peroxidase (Santa Cruz Biotechnologies, USA). The blots were developed using luminol (Thermo Scientific, USA) and measured on Versa doc imaging system (Model 4000; BioRed, USA). Densitometry for protein specific band was done using AlphaEase FC StandAlone V. 4.0.0 software. β-Actin was used as an internal control to normalize the band density.
+ Open protocol
+ Expand
2

Ras Protein Extraction and Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
All strains were grown in GMM+YE overnight at 37 °C with agitation at 250 rpm. The resulting fungal mass was filtered and rinsed with sterile, deionized water, and crushed with liquid nitrogen. The macerated hyphal material was resuspended in 1:1 volumes of extraction buffer (25 mM Tris-HCl [pH 7.5], 10mM MgCl2, 150 mM NaCl, 1 mM EDTA, 0.01% NP-40, 2% glycerol, 1 mM Pefabloc [Sigma], 1 mM protein inhibitor cocktail [Sigma]), and the resulting crude lysates were centrifuged at 3,500 rpm for 9 min at 4°C. Cleared lysates were then transferred to new tubes and the total protein concentration was quantified using the Bradford assay. Fifty milligrams of cleared lysate were boiled before SDS-PAGE separation. Membranes were probed with the anti-Ras, clone RAS10 mouse monoclonal primary antibody (1:2000 dilution, EMD Millipore) and followed by the secondary antibody, a horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG2a (1:2000 dilution, Abcam). Blots were imaged using a Bio-Rad ChemiDoc XRS HQ System and QuantityOne software (v4.6.5, Bio-Rad). The assay was performed in biologic triplicate for each strain.
+ Open protocol
+ Expand
3

Western Blot Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extracts were prepared from LCLs whole cell lysates using CelLytic M cell lysis solution and Protein inhibitor cocktail (Sigma). Western blots were prepared in duplicates, using equivalent protein concentrations and Novex NuPAGE Tris-Acetate gel electrophoresis (Invitrogen). Primary antibodies were incubated with the membrane overnight at 4°C in 5% skimmed milk and detected using secondary antibodies (Supplementary Material, Table S2). ECL (Amersham) was used for signal detection.
+ Open protocol
+ Expand
4

Proteome Profiling of CRC Cells and Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRC cell line pellet samples (2 × 108 cells per replicate, four replicates per cell line) were resuspended with PBS up to 2 ml and then solubilized by adding 2 ml of ice-cold 2× lysis buffer (1% w/v CHAPS). Tumor and NAT samples (average 568 mg) were cut into small pieces (cubes, ∼3 mm in size), and 5 ml of ice-cold PBS containing protein inhibitor cocktail (Sigma, cat#P8340-5 ml) was added. Tissues were first homogenized twice for 20 s using an Ultra Turrax T25 homogenizer (IKA-Labortechnik) set at a speed of 20,000 rpm and then 20 s using an Ultra Turrax T8 homogenizer (IKA-Labortechnik) set at speed 25,000 rpm. Then, 550 μl of ice-cold 10× lysis buffer (5% w/v CHAPS) was added to each sample. After 60-min incubation with tumbling at 4 °C, tissue samples and CRC cell line samples were spun at 10,000g for 30 min at 4 °C. Supernatants were transferred into tubes containing 1 mg of W6/32 antibody covalently cross-linked protein A magnetic beads, and MAPs were immunoprecipitated as described (30 ). MAP extracts were then dried using a Speed-Vac and kept frozen before MS analyses.
+ Open protocol
+ Expand
5

SARS-CoV-2 RBD Crosslinking and Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293TN and hACE2-HEK 293 TN cells were grown at 90% confluency in 150 mm plates. Cells were then detached in PBS. After 3 washes, cells were resuspended in PBS buffer containing 20 μg/ml of recombinant SARS-CoV-2-RBD and incubated with agitation at 4 °C for 60’. Primary amine crosslinker Disuccinimidyl Suberate (DSS) (Thermo Fisher Scientific cat no. 21555) was then added to the mix at a 2 mM final concentration. Crosslinking reactions were performed at room temperature (RT) for 30 min in agitation and were then quenched by addition of 20 mM of TRIS pH 7.4 for 15’.20 (link) After two additional washes in PBS, cells were lysed in the following buffer: 50 mM TRIS pH 7.4, 150 mM NaCl, 1% TRITON and 1:100 protein inhibitor cocktail (Sigma–Aldrich cat no. P8340).
1 mg of total cell lysates were then incubated for 2 h at 4οC in constant rotation with protein G Dynabeads (Life technologies cat. No. 10004D) previously incubated with 25 μg/ml of anti-hACE2 antibodies (R&D systems, cat no. AF933). The beads were then washed three times with lysis buffer and proteins were eluted from the beads by incubation at 95 °C for 10 min with 2X Laemmli sample buffer. Immunoprecipitated samples were then loaded on separate gels for silver staining (to control Immunoprecipitation efficiency), coomassie blue staining (for subsequent mass spectrometry analysis) and western blotting.
+ Open protocol
+ Expand
6

Western Blot Analysis of HCN Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was carried out for different HCN proteins (1-4) in the bladder tissue. Briefly, bladder tissue was homogenized using CelLytic™ MT Mammalian Tissue Lysis/Extraction Reagent (Sigma, USA) in the presence of phenylmethylsulfonyl fluoride (1 mM), sodium orthovanadate (2 mM) and protein inhibitor cocktail (Sigma, USA). Protein estimation was done by BCA Protein Assay Kit (Pierce, Rockford, Illinois). An equal amount (50 μg/well) of denatured proteins was loaded in 10% tricine-SDS gel and blotted on polyvinylidene fluoride (PVDF) membranes using wet transfer system. After blocking (2 h at 37°C), membranes were incubated overnight at 4°C with primary antibodies specific for HCN1, HCN4 and Actin-β (Santa Cruz Biotechnology), HCN2 and HCN3 (Abcam, USA), in blocking buffer (pH 7.5). The membranes were then re-incubated for 2 h at room temperature with secondary immunoglobulin G (IgG)-conjugated with horseradish peroxidase (Santa Cruz Biotechnologies, USA). The blots were developed using luminol (Thermo Scientific, USA) and measured on Versa doc imaging system (Model 4000; BioRed, USA). Densitometry for protein specific band was done using AlphaEase FC StandAlone V. 4.0.0 software. β-Actin was used as an internal control to normalize the band density.
+ Open protocol
+ Expand
7

Western Blot Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extracts were prepared using 1X RIPA buffer (Cell Signaling Technologies) and a final concentration of 0.5 mM PMSF and 1X protein inhibitor cocktail (Sigma). Protein concentration was determined by BCA assay (Pierce). Protein extracts were diluted in 4X LDS sample buffer (Life Technologies) to which DTT had been added to achieve a 50 mM final concentration. Samples were heated to 70 °C for 10 minutes, run on 10% polyacrylamide gels then transferred to PVDF membrane (PerkinElmer) using a semi-dry blot apparatus (Bio-Rad). Membranes were blocked with a 5% blocking buffer (Bio-Rad), incubated in primary antibodies; Pcpe2 (Abcam, Ab23272), CD36 (R&D AF2519), beta-actin (Sigma A2228) SR-BI (Novus, NB400–101) at 4 °C overnight. The next day the blot was washed and treated with a horseradish peroxidase-conjugated secondary antibody for 30 minutes at room temperature. Finally, blots were washed and incubated with Clarity (Bio-Rad, 170–5060) and visualized with X-ray film. Band intensities were compared using ImageJ software (NIH).
+ Open protocol
+ Expand
8

Cell Lysis and Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested and washed with PBS at room temperature. Cells were incubated for 40 min in an ice-cold lysis buffer (10 mM Tris-HCl, pH 7.5, 80 mM NaCl, 1% Triton X-100, 1 mM dithiothreitol, 1 mM PMSF, 10 mM NaF, 2 mM Na3VO4 and 10 µg/ml protein inhibitor cocktail, Sigma Aldrich). The lysates were centrifuged at 800×g for 5 min at 4°C and stored at −20°C. The protein content was determined by the Bradford assay. Total cell lysates were analyzed by SDS-PAGE and immunoblotting as described [60] (link) using the antibodies described in table 2 (Table 2 and Table S1).
+ Open protocol
+ Expand
9

Quantifying GAP-43 and ATF-3 in DRG and Sciatic Nerve

Check if the same lab product or an alternative is used in the 5 most similar protocols
DRG or sciatic samples were homogenized in lysis buffer (1% Triton, 20 mM Tris pH 7.6, 1 mM EDTA, 150 mM NaCl, 1 mM NaF, 1 mM NaVO3) with protein inhibitor cocktail (Sigma) followed by total protein quantification. Proteins were resolved in 12% SDS-PAGE gel and transferred to a nitrocellulose membrane (Bio-Rad). The membrane was then blocked with 5% non-fat milk in TBS-T solution for 1 h, followed by incubation with anti-GAP-43 (sciatic sample, Santa Cruz, RRID:AB_640874), anti-ATF-3 (DRG sample, Santa Cruz, RRID:AB_2258513) or anti-β-actin/actin primary antibody overnight at 4°C (1:1000, Santa Cruz, RRID:AB_2223228 /Millipore, RRID:AB_2223041). On the next day, anti-rabbit secondary antibody was incubated for 1 h and chemiluminescence was measured using a ChemiDoc XRS+ imaging system (Bio-Rad) after development in chemiluminescence reagent (Westar Nova 2011, CYANAGEN). Bands intensity was determined using ImageJ software (NIH, United States).
+ Open protocol
+ Expand
10

PPARγ and AMPK Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed twice with ice-cold PBS and subsequently lysed in equal volumes of cell lysis buffer containing protein inhibitor cocktail (Sigma) for 30 min. Protein concentration was measured by BCA protein assay kit (Pierce). The lysates mixed with a certain amount of 5 × loading buffer and boiled at 100 ℃ for 10 min. The protein was separated by 10% SDS-PAGE and transferred to PVDF membrane, blocked in 5% non-fat dried milk dissolved in PBS-T for 1 h and immunoblotted with antibodies specific for PPARγ, FABP4, t-AMPKα, P-AMPKT172, t-ACC, P-ACCS79 and β-actin. Finally, the immunoblots were quantified using the Metamorph software and expressed as a ratio of phosphorylated to total protein or total protein to β-actin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!